Skip to main content
GLPG
NASDAQ Life Sciences

加拉帕戈斯将资助盖乐德1.675亿美元欧罗收购的半数，为自身获得5亿美元现金灵活性，以合作开发用于自身免疫疾病的药物

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
9
Price
$32.01
Mkt Cap
$2.11B
52W Low
$22.591
52W High
$37.78
Market data snapshot near publication time

summarizeSummary

加拉帕戈斯和盖乐德正在进行高级别的讨论，以围绕欧罗医药的临床阶段T细胞引发器程序（OM336）建立战略合作伙伴关系，用于自身免疫疾病，这是继盖乐德达成1.675亿美元现金和高达5亿美元的里程碑付款的欧罗收购协议之后。根据提出的条款，加拉帕戈斯将为欧罗收购的前期付款和里程碑付款贡献50%，吸收欧罗的运营资产和员工，并与盖乐德分享OM336的开发成本，同时盖乐德保留全球商业化权（不包括中国）并向加拉帕戈斯支付净销售额的20-23%的特许权使用费。关键的是，加拉帕戈斯和盖乐德之间的传统选择许可和合作协议（OLCA）将被修订，为加拉帕戈斯提供了使用其当前现金的灵活性，最高可达5亿美元，包括高达1.5亿美元的潜在股份回购。这代表着加拉帕戈斯的一项高度重要的战略和财务发展，获得了一个有前途的资产，同时显著增强了其资本配置的灵活性。投资者将关注这些合作条款的最终确定以及OM336临床计划的进一步更新。

在该公告发布时，GLPG的交易价格为$32.01，交易所为NASDAQ，所属行业为Life Sciences，市值约为$21.1亿。 52周交易区间为$22.59至$37.78。 这则新闻被评估为积极市场情绪，重要性评分为9/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed GLPG - Latest Insights

GLPG
Apr 29, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Shareholders Approve Rebranding to Lakefront Biotherapeutics, 10% Share Buyback Authorization, and New Board Chair
Sentiment: Positive
View Wiseek Article
GLPG
Mar 31, 2026, 1:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
$500M Cash Pool, $150M Buyback Authorized for Galapagos in Binding Gilead Collaboration
Sentiment: Positive
View Wiseek Article
GLPG
Mar 30, 2026, 9:41 PM EDT
Filing Type: 6-K
Importance Score:
9
Galapagos Finalizes Binding Agreement with Gilead for Ouro Medicines' T-Cell Engager Program, Gains $500M Strategic Flexibility
Sentiment: Positive
View Wiseek Article
GLPG
Mar 30, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Galapagos Proposes Rebranding to Lakefront Biotherapeutics, Authorizes Share Buyback, and Appoints New Board Chair
Sentiment: Positive
View Wiseek Article
GLPG
Mar 26, 2026, 4:02 PM EDT
Filing Type: 20-F
Importance Score:
9
Galapagos NV Pivots to New Strategy, Exits Cell Therapy, Proposes Name Change to Lakefront Biotherapeutics
Sentiment: Neutral
View Wiseek Article
GLPG
Mar 23, 2026, 6:58 PM EDT
Filing Type: 6-K
Importance Score:
8
Galapagos & Gilead Detail Strategic Collaboration for Autoimmune T-Cell Engager; Galapagos to Fund Half of $1.675B Acquisition & Gain $500M Cash Flexibility
Sentiment: Positive
View Wiseek Article
GLPG
Mar 23, 2026, 6:25 PM EDT
Source: GlobeNewswire
Importance Score:
9
Galapagos to Fund Half of Gilead's $1.675B Ouro Acquisition for Autoimmune Drug Collaboration, Gains $500M Cash Flexibility
Sentiment: Positive
View Wiseek Article
GLPG
Mar 17, 2026, 5:26 PM EDT
Filing Type: 6-K
Importance Score:
7
Bank of America Reduces Stake in Galapagos Below 5% Threshold
Sentiment: Negative
View Wiseek Article
GLPG
Mar 06, 2026, 4:28 PM EST
Filing Type: 6-K
Importance Score:
7
Galapagos Board Approves New Employee Subscription Right Plan for 1.75 Million Shares
Sentiment: Neutral
View Wiseek Article
GLPG
Mar 05, 2026, 4:28 PM EST
Filing Type: 6-K
Importance Score:
7
Galapagos Appoints Tania Philipp as New CHRO to Drive Culture Transformation
Sentiment: Positive
View Wiseek Article